收藏切换
Research advances of targeting DNA damage response in small cell lung cancer
收藏切换
PDF
Song-Yun Zhao1, Zhi-Jie Wan2, Xi-Yuan Cao1, Yan-Yong Yang2, Chong Bai1, *
Medical Journal of Chinese People’s Liberation Army | 2022, 47(8) : 838 - 844
Less
收藏切换
Medical Journal of Chinese People’s Liberation Army | 2022, 47(8): 838-844
Review
Research advances of targeting DNA damage response in small cell lung cancer
Full
Song-Yun Zhao1, Zhi-Jie Wan2, Xi-Yuan Cao1, Yan-Yong Yang2, Chong Bai1, *
Affiliations
  • 1Department of Respiratory and Critical Care Medicine, Changhai Hospital, Naval Medical University, Shanghai 200433, China
  • 2Department of Marine Radiation Medicine, Faculty of Naval Medicine, Naval Medical University, Shanghai 200433, China
Published: 2022-08-28 doi: 10.11855/j.issn.0577-7402.2022.08.0838
Outline
收藏切换

Small cell lung cancer (SCLC) is an aggressive malignancy with a 5-year survival rate of 7.2%, which is characterized by exceptionally high proliferation rate, early metastasis, and poor prognosis. In the face of DNA damage and replicative stress, the DNA damage response (DDR) elicits activation of cell cycle checkpoints to promote repair by pausing the cell cycle or, in cases of unrepairable DNA damage, stimulate programmed cell death. SCLC carries a high mutation burden and genomic instability, and almost all SCLC tumors have functional inactivation of both TP53 and RB1, which leads to the form of a dysfunctional G1/S checkpoint and results in an increased reliance on subsequent cell cycle checkpoints (S, G2/M) to ensure genome stability and correct chromosomal segregation. Therefore, under the use of radio-chemotherapy for DNA damaging, promoting the cell cycle progress by inhibiting the cycle checkpoints and increasing DNA damage by inhibiting DNA damage repair can be new strategies for targeted therapies in SCLC. In the present article, we review the advances of targeting DDR and it's pathway inhibitors in SCLC, and provide some thoughts for the targeted treatment strategies of SCLC.

DNA damage  /  DNA repair  /  small cell lung cancer  /  targeted therapy
Song-Yun Zhao, Zhi-Jie Wan, Xi-Yuan Cao, Yan-Yong Yang, Chong Bai. Research advances of targeting DNA damage response in small cell lung cancer[J]. Medical Journal of Chinese People’s Liberation Army, 2022 , 47 (8) : 838 -844 . DOI: 10.11855/j.issn.0577-7402.2022.08.0838
Year 2022 volume 47 Issue 8
PDF
314
151
Cite this Article
BibTeX
Article Info
doi: 10.11855/j.issn.0577-7402.2022.08.0838
  • Receive Date:2021-07-26
  • Online Date:2025-12-15
  • Published:2022-08-28
Article Data
Affiliations
History
  • Received:2021-07-26
  • Accepted:2021-09-06
Affiliations
    1Department of Respiratory and Critical Care Medicine, Changhai Hospital, Naval Medical University, Shanghai 200433, China
    2Department of Marine Radiation Medicine, Faculty of Naval Medicine, Naval Medical University, Shanghai 200433, China

Corresponding:

References
Share
https://castjournals.cast.org.cn/joweb/jfjyxzz/EN/10.11855/j.issn.0577-7402.2022.08.0838
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT